The DOI matches its Crossref record; 31 of the 34 references it cites were found in a registry or an index.
Estradiol supplementation enhances submaximal feed-forward drive of growth hormone (GH) secretion by recombinant human GH-releasing hormone-1,44-amide in a putatively somatostatin-withdrawn milieu.
Abstract
To test the clinical hypothesis that an estrogen-enriched milieu enhances GHRH action, we administered placebo (Pl) and estradiol-17β (E2) orally for 23 d to six postmenopausal women in a prospectively randomized, double-masked, within-subject crossover design with 6 wk intervening. The GHRH stimulation protocol entailed consecutive iv infusion of l-arginine and a single iv pulse of saline or one of five randomly ordered doses of recombinant human GHRH-1,44-amide (0.03, 0.1, 0.3, 1.0, or 3.0 μg/kg) in a total of 12 separate morning, fasting sessions. GH secretion was monitored by sampling blood every 10 min for 6 h; chemiluminescence assay of GH concentrations; deconvolution analysis of stimulated GH release; and nonlinear dose-response reconstruction. Supplementation with E2, compared with Pl: 1) increased (mean ± sem) E2 concentrations from 18 ± 3 (Pl) to 164 ± 12 pg/ml (to convert to picomoles per liter, multiply by 3.57) (P < 0.001); 2) decreased IGF-I concentrations from 181 ± 14 to 120 ± 11 μg/liter (P < 0.01); 3) elevated mean GH concentrations from 0.27 ± 0.06 to 0.59 ± 0.08 μg/liter (P = 0.014); 4) potentiated GH secretion stimulated by l-arginine alone by 1.43-fold (P = 0.012); 5) reduced the ED50 of GHRH from 0.27 ± 0.02 to 0.13 ± 0.01 μg/kg (P < 0.01), denoting enhanced GHRH potency; and 6) heightened the maximal slope of the dose-response function from 1.1 ± 0.1 to 1.4 ± 0.05 [(μg/liter) (μg/kg)−1] (P < 0.05), signifying augmented pituitary sensitivity. The foregoing facilitative mechanisms were specific because E2 replacement did alter maximal l-arginine/GHRH-induced GH secretion, indicating unchanged secretagogue efficacy. In conclusion, inasmuch as E2 also attenuates inhibition of GH secretion by infused somatostatin and potentiates stimulation of GH secretion by GH-releasing peptide-2, we postulate that estrogenic steroids drive pulsatile GH production in part via mechanisms that include all three of GHRH, somatostatin, and putatively GH-releasing peptide/ghrelin signaling.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The foregoing peptide doses were chosen as maximally stimulatory in dose-response analyzes in women (31,33).”
From Determinants of dual secretagogue drive of burst-like growth hormone secretion in premenopausal women studied under a selective estradiol clamp (2005) · cites this paper as [33]
In the citing paper
“clinical investigations indicate that E 2 supplementation in postmenopausal women augments stimulation by GHRP-2 and submaximal drive by GHRH”
From Determinants of dual secretagogue drive of burst-like growth hormone secretion in premenopausal women studied under a selective estradiol clamp (2005) · cites this paper as [33]
Citations
Cites
DeLean, A., Munson, P. J., & Rodbard, D. (1978) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1978.235.2.e97 · Cited by 2,374
Giustina, A., & Veldhuis, J. D. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.6.0353 · Cited by 1,253
Self-citationHO, K. Y., EVANS, W. S., BLIZZARD, R. M., VELDHUIS, J. D., MERRIAM, G. R., SAMOJLIK, E., FURLANETTO, R., ROGOL, A. D., KAISER, D. L., & THORNER, M. O. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-1-51 · Cited by 921
Self-citationVeldhuis, J. D., Carlson, M. L., & Johnson, M. L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7686 · Cited by 549
Self-citationEffects of Estrogen and Sex Difference on Secretion of Human Growth Hormone1
FRANTZ, A. G., & RABKIN, M. T. (1965) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-25-11-1470 · Cited by 467
Arginine Stimulates Growth Hormone Secretion by Suppressing Endogenous Somatostatin Secretion*
ALBA-ROTH, J., MÜLLER, O. A., SCHOPOHL, J., & WERDER, K. V. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-6-1186 · Cited by 337
van den Berg, G., Veldhuis, J. D., Frölich, M., & Roelfsema, F. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.7.8675561 · Cited by 293
Self-citation[26] Deconvolution analysis of hormone data
.Veldhuis, J. D., & Johnson, M. L. (1992) · Methods in Enzymology · doi:10.1016/0076-6879(92)10028-c · Cited by 263
Self-citationShuto, Y., Shibasaki, T., Otagiri, A., Kuriyama, H., Ohata, H., Tamura, H., Kamegai, J., Sugihara, H., Oikawa, S., & Wakabayashi, I. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213300 · Cited by 220
Hartman, M. L., Clayton, P. E., Johnson, M. L., Celniker, A., Perlman, A. J., Alberti, K. G., & Thorner, M. O. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116480 · Cited by 192
Research works printed but not linked: 1
- Anderson, 2002, Estrogen supplementation enhances rhIGF-I suppression of GH secretion in postmenopausal women, 14
Cited by
Somatotropic and Gonadotropic Axes Linkages in Infancy, Childhood, and the Puberty-Adult Transition
Veldhuis, J. D., Roemmich, J. N., Richmond, E. J., & Bowers, C. Y. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0006 · Cited by 236
Self-citationNeuroendocrine Regulation of Growth Hormone Secretion
Steyn, F. J., Tolle, V., Chen, C., & Epelbaum, J. (2016) · Comprehensive physiology · doi:10.1002/cphy.c150002 · Cited by 193
Veldhuis, J. D. (2008) · Ageing Research Reviews · doi:10.1016/j.arr.2007.12.005 · Cited by 111
Self-citationGrinspoon, S. K., Miller, K. K., Herzog, D. B., Grieco, K. A., & Klibanski, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0287 · Cited by 54
Veldhuis, J. D., Mielke, K. L., Cosma, M., Soares-Welch, C. V., Paulo, R., Miles, J. M., & Bowers, C. Y. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2108 · Cited by 45
Self-citation
Metadata
- Authors
- Veldhuis, J. D., Evans, W. S., & Bowers, C. Y.
- Affiliations
- Mayo Clinic (US)
- University of Virginia (US)
- Tulane University (US)
- Corresponding author
- Veldhuis, Johannes D.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-11-01
- Volume
- 88
- Issue
- 11
- Pages
- 5484-5489
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2063862321
- Cited by
- 46
- References
- 34
- Citations by year
- 2016: 3 · 2013: 3 · 2012: 1
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsches Krebsforschungszentrum
- National Institutes of Health (1r03ag014779-01)
- National Institute on Aging (R01 AG19596, AG14779)
- National Center for Research Resources (M01-RR00 585, M01RR000847, M01RR000585, M01-RR 00847)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- estradiol supplementation, growth hormone secretion, growth hormone-releasing hormone, postmenopausal women, insulin-like growth factor I, L-arginine, deconvolution
- MeSH terms
- Aged, Arginine, Drug Synergism, Estradiol, Female, Humans, Middle Aged, Pituitary Gland, Prospective Studies, Growth Hormone-Releasing Hormone, Postmenopause, Cross-Over Studies, Human Growth Hormone, Feedback, Physiological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Estradiol supplementation enhances submaximal feed-forward drive of growth hormone (GH) secretion by recombinant human GH-releasing hormone-1,44-amide in a putatively somatostatin-withdrawn milieu. https://app.cochat.ai/papers/10.1210/jc.2003-030410
- The paper
- Veldhuis, J. D., Evans, W. S., & Bowers, C. Y. (2003). Estradiol supplementation enhances submaximal feed-forward drive of growth hormone (GH) secretion by recombinant human GH-releasing hormone-1,44-amide in a putatively somatostatin-withdrawn milieu. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2003-030410
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.